VOR: Vor Biopharma Inc. Stock

by  •  • Comments Off on VOR: Vor Biopharma Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 115.97
Enterprise Value ($M) 84.61
Book Value ($M) 150.72
Book Value / Share 2.21
Price / Book 0.77
NCAV ($M) 93.40
NCAV / Share 1.37
Price / NCAV 1.24

Profitability (mra)
Return on Invested Capital (ROIC) -0.63
Return on Assets (ROA) -0.42
Return on Equity (ROE) -0.51

Liquidity (mrq)
Quick Ratio 9.04
Current Ratio 9.04

Balance Sheet (mrq) ($M)
Current Assets 140.80
Assets 198.13
Liabilities 47.40
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -126.04
Net Income -117.86

Cash Flow Statement (mra) ($M)
Cash From Operations -100.29
Cash from Investing 71.01
Cash from Financing 2.94

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Paradigm Biocapital Advisors LP 9.50 -0.32
02-14 13D/A 5AM Ventures VI, L.P. 9.40 -4.94
02-09 13G/A Fmr Llc 11.24 -4.41
08-11 13D/A Ra Capital Management, L.p. 33.70 0.09

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 31,931 137,864 23.16
2024-04-25 46,355 152,040 30.49
2024-04-24 73,943 268,427 27.55
2024-04-23 43,279 48,815 88.66
2024-04-22 31,294 46,076 67.92

(click for more detail)

Similar Companies
VIGL – Vigil Neuroscience, Inc. VIR – Vir Biotechnology, Inc.
VIRX – Viracta Therapeutics, Inc. VRTX – Vertex Pharmaceuticals Incorporated
VTRS – Viatris Inc.


Financial data and stock pages provided by
Fintel.io